Press Releases

Press Releases

Our 3rd Annual Drug Discovery USA Congress which will take place on the 3rd & 4th October 2016 in San Diego, California, is designed as a high-level strategy-focused meeting for drug discovery and medicinal chemistry experts based in the USA. The meeting will feature exciting streams dedicated to different aspects…

Press Releases

Brammer Biopharmaceuticals today announces its merger with Florida Biologix to create the best-in-class cell and gene therapy biologics contract development and manufacturing organization (CDMO). The merged company, Brammer Bio, will combine deep technical expertise in process development and clinical manufacturing with demonstrated capabilities, operating approaches and the quality standards required…

Press Releases

Lexicon Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of telotristat etiprate, an oral drug for the treatment of carcinoid syndrome. The FDA has a 60-day filing review period to determine whether…

Press Releases

Aldevron announced the completion of a 4,500-square-foot expansion of its GMP and GMP-Source™ biological manufacturing facilities in Fargo, North Dakota. The project increases the company’s available production capacity by over 35%. This expansion is in response to increasing demand for Aldevron’s custom plasmid, therapeutic RNA transcript, and enzyme services, and…

DiscoverX Launches KILR™ Assay Platform for use in Cancer Immunotherapy Drug Development

DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced the launch of the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line. Recent advances in the development of cancer immunotherapies using…

Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION™

Ampio Pharmaceuticals, Inc. announced today that enrollment is now complete in the PIVOT trial of Ampion™ for the treatment of pain due to osteoarthritis-of-the-knee (OAK). Michael Macaluso, Ampio's CEO explained: "The PIVOT trial is a randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of an intra-articular injection of…

BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 Million

BioPharmX Corporation, a specialty pharmaceutical company focusing on dermatology and women's health, today announced the pricing of an underwritten public offering of 3,600,000 shares of common stock and warrants to purchase 1,800,000 shares of common stock with a public offering price of $1.20 for one share of common stock and…

Press Releases

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad-spectrum, topical antimicrobial peptide, today announced that the government of Japan has issued a Locilex patent. The patent claims are directed to a novel formulation of Locilex, an antimicrobial peptide…

Press Releases

Eiger BioPharmaceuticals, Inc. today announced that the European Medicines Agency (EMA) has granted Orphan Medicinal Product status to ubenimex for the treatment of pulmonary arterial hypertension (PAH). "We are very pleased with the EMA Committee of Orphan Medicinal Products (COMP) designation of orphan status for ubenimex in PAH," said Joanne…

Press Releases

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, today announced two executive appointments reflecting the evolution of the company from a development oriented company to a commercially focused organization. Abraham (Abe) Ceesay was appointed Chief Operating Officer and Troy Ignelzi was named Chief Financial…